“Governtment of India is considering to set-up a structured regulation for AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy) medicines” said Shripad Yesso Naik , Minister of State for AYUSH. In 2003, the Department of Indian System of Medicine and Homeopathy (ISM&H) was renamed to Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH). Presently, there are no formalized rules for AYUSH medicine regulations while the registration of medical devices in India is handled by the Central Drug Standards and Control Organization. (Documents required for CDSCO registration in India, Step by Step Process to Register Your Medical Device in India).
The AYUSH department is focusing on education and research in the field of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH). It is an independent ministry effective November, 2014. “Government has initiated procedural steps for setting up the vertical structure for AYUSH in the Central Drug Standards and Control Organization (CDSCO) and the need for creation of a separate drug Controller General for AYUSH may be assessed subsequently, the time frame for which cannot be specified at this stage” Shripad Yesso Naik added.
Other News
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
TGA Supports MHRA’s New Regulations
The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]
Read MoreMedical Devices with Extended CE Certification Are Now Accepted On The UK Market
The MHRA revised its guidelines to make clear its stance and reflect its intention to extend the acceptance of CE-marked medical devices on the British market beyond June 30th, 2023. A statutory document that will […]
Read More
The NMPA Enhanced Regulation of Cosmetic Medicine
According to a representative of the State Administration for Market Regulation, after the industry’s quick development, prominent issues like unethical medical practices, fake goods, false advertising, and price fraud emerged, endangering the health and interests […]
Read More
